[1]
Song, X. 2013. Targeting of both PI3K/Akt/mTOR pathway and mutant EGFR to overcome resistance to tyrosine kinase inhibitors in mutant EGFR-mediated lung cancer. Onco Reviews. 1, 1 (Nov. 2013), pp.13–19. DOI:https://doi.org/10.14259/or.v1i1.81.